The vitamin D receptor and the syndrome of hereditary 1,25- dihydroxyvitamin D-resistant rickets

Endocrine Reviews

Volumn 20, Issue 2, 1999, Pages 156-188

  Malloy, Peter J ^a   Pike, J Wesley ^b   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; DOXERCALCIFEROL; OXYGENASE; VITAMIN D; VITAMIN D RECEPTOR;

ALOPECIA; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HORMONE ACTION; HORMONE RESISTANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SKIN FIBROBLAST; STRUCTURE ANALYSIS; SYNDROME; TRANSACTIVATION; VITAMIN D METABOLISM; VITAMIN D RESISTANT RICKETS;

AMINO ACID SEQUENCE; ANIMALS; CALCITRIOL; FEMALE; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 0032780531     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.20.2.156     Document Type: Article

References (273)

1. 3 in normal physiology. Mol Cell Endocrinol 72:C57-C62
2. 3 receptor. J Recept Res 11:699-716
3. 3. Malloy PJ, Pike JW, Feldman D 1997 Hereditary 1,25-dihydroxyvitamin D resistant rickets. In: Feldman D, Glorieux F, Pike, JW (eds) Vitamin D. Academic Press, San Diego, CA, pp 756-788
4. 4. Feldman D, Glorieux FH, Pike JW (eds) 1997 Vitamin D. Academic Press, San Diego, CA
5. 5. Brooks MH, Bell NH, Love L, Stern PH, Orfei E, Queener SF, Hamstra AJ, DeLuca HF 1978 Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med 298:996-999
6. 6. Marx SJ, Spiegel AM, Brown EM, Gardner DG, Downs Jr RW, Attie M, Hamstra AJ, DeLuca HF 1978 A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 47:1303-1310
7. 7. Rosen JF, Fleischman AR, Finberg L, Hamstra A, DeLuca HF 1979 Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr 94:729-735
8. 8. Liberman UA, Samuel R, Halabe A, Kauli R, Edelstein S, Weisman Y, Papapoulos SE, Clemens TL, Fraher LJ, O'Riordan JL 1980 End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 1:504-506
9. 3. J Pediatr 96:701-703
10. 10. Kudoh T, Kumagai T, Uetsuji N, Tsugawa S, Oyanagi K, Chiba Y, Minami R, Nakao T 1981 Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D. Eur J Pediatr 137: 307-311
11. 11. Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, Guillozo H, Grimberg R, Le Deunff MJ, Lieberherr M, Guimbaud P, Broyer M, Marx SJ 1983 Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. J Clin Endocrinol Metab 57:803-811
12. 12. Laufer D, Benderly A, Hochberg Z 1987 Dental pathology in calcitirol resistant rickets. J Oral Med 42:272-275
13. 13. Bliziotes M, Yergey AL, Nanes MS, Muenzer J, Begley MG, Viera NE, Kher KK, Brandi ML, Marx SJ 1988 Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. J Clin Endocrinol Metab 66:294-300
14. 3 in a patient without alopecia. Eur J Pediatr 145:389-395
15. 15. Beer S, Tieder M, Kohelet D, Liberman OA, Vure E, Bar-Joseph G, Gabizon D, Borochowitz ZU, Varon W, Modai D 1981 Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf) 14:395-402
16. 3. J Clin Endocrinol Metab 55:1020-1022
17. 17. Hochberg Z, Benderli A, Levy J, Vardi P, Weisman Y, Chen T, Feldman D 1984 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia. Am J Med 77:805-811
18. 18. Hirst MA, Hochman HI, Feldman D 1985 Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J Clin Endocrinol Metab 60:490-495
19. 3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics 80:97-101
20. 20. Yagi H, Ozono K, Miyake H, Nagashima K, Kuroume T, Pike JW 1993 A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Clin Endocrinol Metab 76:509-512
21. 21. Malloy PJ, Weisman Y, Feldman D 1994 Hereditary 1α,25-dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J Clin Endocrinol Metab 78:313-316
22. 3 resistant rickets in seven related families. J Clin Invest 86:2071-2079
23. 23. Heaney RP 1997 Vitamin D: role in the calcium economy. In: Feldman D, Glorieux F, Pike JW (eds) Vitamin D. Academic Press, San Diego, CA, pp 485-497
24. 24. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF 1997 Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82:4111-4116
25. 25. Hochberg Z, Gilhar A, Haim S, Friedman-Bimbaum R, Levy J, Benderly A 1985 Calcitriol-resistant rickets with alopecia. Arch Dermatol 121:646-647
26. 26. Marx SJ, Bliziotes MM, Nanes M 1986 Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf) 25:373-381
27. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188-1190
28. 28. Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC 1988 Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab 67:607-613
29. 3 receptors: structure and function in transcription. Ann Rev Nutr 11:189-216
30. 30. Haussler MR, Whitfield GK, Haussler CA, Hsieh J, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349
31. 3 receptors: gene regulation and genetic circuitry. FASEB J 2:3043-3053
32. 32. Haussler MR, McCain TA 1977 Basic and clinical concepts related to vitamin D metabolism and action. N Engl J Med 297:1041-1050
33. 33. DeLuca HF 1979 The vitamin D system in the regulation of calcium and phosphorus metabolism. Nutr Rev 37:161-193
34. 34. Haussler MR, Norman AW 1969 Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 62:155-162
35. 35. Brumbaugh PF, Haussler MR 1974 1α,25-Dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor. J Biol Chem 249:1258-1262
36. 3 in chick parathyroid glands. Proc Natl Acad Sci USA 72:4871-4875
37. 3 in fetal bone. Science 197:1086-1088
38. 3 in rat intestine. J Biol Chem 252:4501-4505
39. 3 in human intestine. J Clin Endocrinol Metab 48:715-717
40. 40. Chen TL, Hirst MA, Feldman D 1979 A receptor-like binding macromolecule for 1α,25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem 254:7491-7494
41. 41. Colston KW, Feldman D 1979 Demonstration of 1α,25-dihydroxycholecalciferol cytoplasmic receptor-like binder in mouse kidney cytosol. J Clin Endocrinol 49:798-800
42. 42. Feldman D, McCain TA, Hirst MA, Chen TL, Colston KW 1979 Characterization of a cytoplasmic receptor-like binder for 1α, 25-dihydroxycholecalciferol in rat intestinal mucosa. J Biol Chem 254: 10378-10384
43. 43. Colston K, Hirst M, Feldman D 1980 Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology 107:1916-1922
44. 3 receptor in target cells. Endocrinology 122:1224-1230
45. 45. Bikle DD 1992 Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev 13:765-784
46. 46. Walters MR 1992 Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764
47. 3 receptors and actions in prostate cancer cell lines. Endocrinology 132:1952-1960
48. 48. Feldman D, Malloy PJ, Gross C 1996 Vitamin D: metabolism and action. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, CA, pp 205-235
49. 49. Reichel H, Koeffler HP, Norman AW 1989 The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991
50. 50. Darwish H, DeLuca HF 1993 Vitamin D-regulated gene expression. Crit Rev Eukaryot Gene Expr 3:89-116
51. 51. MacDonald PN, Dowd DR, Haussler MR 1994 New insight into the structure and functions of the vitamin D receptor. Semin Nephrol 14:101-118
52. 52. Manolagas SC, Yu XP, Girasole G, Bellido T 1994 Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin Nephrol 14:129-143
53. 53. Hochberg Z, Borochowitz Z, Benderli A, Vardi P, Oren S, Spirer Z, Heyman I, Weisman Y 1985 Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands? J Clin Endocrinol Metab 60:57-61
54. 54. Even L, Weisman Y, Goldray D, Hochberg Z 1996 Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets. J Clin Endocrinol Metab 81: 2836-2840
55. 55. Etzioni A, Hochberg Z, Pollak S, Meshulam T, Zakut V, Tzehoval E, Keisari Y, Aviram I, Spirer Z, Benderly A, Weisman Y 1989 Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin D. Pediatr Res 25:276-279
56. 56. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396
57. 57. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835
58. 58. Holick MF 1994 McCollum Award Lecture, 1994: Vitamin D - new horizons for the 21st century. Am J Clin Nutr 60:619-630
59. 59. Cooke NE, McLeod JF, Wang XK, Ray K 1991 Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues. J Steroid Biochem Mol Biol 40:787-793
60. 60. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J 1993 Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91:2552-2555
61. 61. Okuda KI 1994 Liver mitochondrial P450 involved in cholesterol catabolism and vitamin D activation. J Lipid Res 35:361-372
62. 62. Henry HL 1992 Vitamin D hydroxylases. J Cell Biochem 49:4-9
63. 63. Holick MF 1995 Vitamin D: photobiology, metabolism, and clinical applications. In: DeGroot LJ, Besser M, Burger HG, Loriaux DL, Marshall JC, Odell WD, Potts JT, Rubentstein AH (eds) Endocrinology. W.B. Saunders, Philadelphia, pp 990-1014
64. 64. Okuda K, Usui E, Ohyama Y 1995 Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism. J Lipid Res 36:1641-1652
65. 3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262:173-180
66. 3 through C-24 oxidation pathway. Biochemistry 28:1763-1769
67. 3 24-hydroxylase. FEBS Lett 278:195-198
68. 68. Guo YD, Strugnell S, Back DW, Jones G 1993 Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci USA 90:8668-8672
69. 69. Hahn CN, Baker E, Laslo P, May BK, Omdahl JL, Sutherland GR 1993 Localization of the human vitamin D 24-hydroxylase gene (CYP24) to chromosome 20q13.2->q13.3. Cytogenet Cell Genet 62:192-193
70. 3 24-hydroxylase gene. J Biol Chem 269:10545-10550
71. 3) 24-hydroxylase gene. Proc Natl Acad Sci USA 91:900-902
72. 72. St-Arnaud R, Glorieux FH 1997 Vitamin D and bone development. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. Academic Press, San Diego, CA, pp 293-304
73. 73. Prader VA, Illig R, Heierli E 1961 Eine besondere form der primaren vitamin-D-resistenten rachitis mit hypocalcamie und autosomal-dominantem erbgang: die hereditare pseudo-mangelrachitis. Helv Paediatr Acta 16:452-468
74. 74. Glorieux FH, St-Arnaud R 1997 Vitamin D pseudodeficiency. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. Academic Press, San Diego, CA, pp 755-764
75. 75. Labuda M, Morgan K, Glorieux FH 1990 Mapping autosomal recessive vitamin D dependency type I to chromosome 12q14 by linkage analysis. Am J Hum Genet 47:28-36
76. 76. Labuda M, Fujiwara TM, Ross MV, Morgan K, Garcia-Heras J, Ledbetter DH, Hughes MR, Glorieux FH 1992 Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14. J Bone Miner Res 7:1447-1453
77. 77. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH 1997 The 25-hydroxyvitamin D 1-α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12:1552-1559
78. 78. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, Portale AA 1997 Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 11:1961-1970
79. 79. Fu GK, Portale AA, Miller WL 1997 Complete structure of the human gene for the vitamin D 1α-hydroxylase, P450c1α. DNA Cell Biol 16:1499-1507
80. 3 1α-hydroxylase. Biochem Biophys Res Commun 239:527-533
81. 3-1α-hydroxylase cDNA. Proc Natl Acad Sci USA 94:12920-12925
82. 3 1α-hydroxylase and vitamin D synthesis. Science 277:1827-1830
83. 3 1α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338:653-661
84. 84. Colston K, Feldman D 1980 Nuclear translocation of the 1,25-dihydroxycholecalciferol receptor in mouse kidney. J Biol Chem 255:7510-7513
85. 85. Walters MR, Hunziker W, Norman AW 1980 1,25-Dihydroxyvitamin D receptors: intermediates between triiodothyronine and steroid hormone receptors. Trends Biochem Sci 6:268-271
86. 86. Pike JW, Haussler MR 1979 Purification of chicken intestinal receptor for 1,25-dihydroxyvitamin D. Proc Natl Acad Sci USA 76: 5485-5489
87. 3. Generation by a preparation enriched in a 64,000-dalton protein. J Biol Chem 258:1289-1296
88. 3: interaction with distinct receptor domains. Biochemistry 25:4523-4534
89. 89. McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW 1987 Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235:1214-1217
90. 90. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298
91. 3 receptor cDNA. Proc Natl Acad Sci USA 85:1005-1009
92. 92. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
93. 93. O'Malley B 1990 The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol 4:363-369
94. 94. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
95. 95. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ 1996 An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature 383:728-731
96. 96. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139
97. 97. Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, Inoue Y, Morita K, Takeda E, Pike JW 1997 Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11:1165-1179
98. 98. Jurutka PW, Hsieh JC, MacDonald PN, Terpening CM, Haussler CA, Haussler MR, Whitfield GK 1993 Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. J Biol Chem 268: 6791-6799
99. 3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry 33:4300-4311
100. 100. Berg JM 1988 Proposed structure for the zinc-binding domains from transcription factor IIIA and related proteins. Proc Natl Acad Sci USA 85:99-102
101. 101. Berg JM 1989 DNA binding specificity of steroid receptors. Cell 57:1065-1068
102. 102. Mader S, Kumar V, de Vemeuil H, Chambon P 1989 Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 338:271-274
103. 103. Umesono K, Evans RM 1989 Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57:1139-1146
104. 104. Hsieh JC, Jurutka PW, Galligan MA, Terpening CM, Haussler CA, Samuels DS, Shimizu Y, Shimizu N, Haussler MR 1991 Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. Proc Natl Acad Sci USA 88:9315-9319
105. 105. Hsieh JC, Jurutka PW, Nakajima S, Galligan MA, Haussler CA, Shimizu Y, Shimizu N, Whitfield GK, Haussler MR 1993 Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. J Biol Chem 268:15118-15126
106. 106. Schwabe JW, Neuhaus D, Rhodes D 1990 Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348:458-461
107. 107. Hard T, Kellenbach E, Boelens R, Maler BA, Dahlman K, Freedman LP, Carlstedt-Duke J, Yamamoto KR, Gustafsson JA, Kaptein R 1990 Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249:157-160
108. 108. Luisi BF, Xu WX, Otinowski Z, Freedman LP, Yamamoto KR, Sigler PB 1991 Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497-505
109. 109. Schwabe JW, Chapman L, Finch JT, Rhodes D 1993 The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75:567-578
110. 110. Lee MS, Kliewer SA, Provencal J, Wright PE, Evans RM 1993 Structure of the retinoid X receptorα DNA binding domain: a helix required for homodimeric DNA binding. Science 260:1117-1121
111. 111. Rastinejad F, Perlmann T, Evans RM, Sigler PB 1995 Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375:203-211
112. 3 receptors. Generation of discrete polypeptides which retain hormone but are unreactive to DNA and monoclonal antibody. J Biol Chem 260:10139-10145
113. 3 receptor. Distinct 20-kDa DNA-binding and 45-kDa hormone-binding species. J Biol Chem 262:1312-1319
114. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558
115. 115. Zhao XY, Eccleshall TR, Krishnan AV, Gross C, Feldman D 1997 Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid × receptor using the yeast two-hybrid system. Mol Endocrinol 11:366-378
116. 116. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
117. 117. Masuyama H, Brownfield CM, St-Arnaud R, MacDonald PN 1997 Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11:1507-1517
118. 118. Gill RK, Atkins LM, Hollis BW, Bell NH 1998 Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1. Mol Endocrinol 12:57-65
119. 119. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
120. 120. Li H, Leo C, Schroen DJ, Chen JD 1997 Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol Endocrinol 11:2025-2037
121. 121. Blanco JC, Wang IM, Tsai SY, Tsai MJ, O'Malley BW, Jurutka PW, Haussler MR, Ozato K 1995 Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 92:1535-1539
122. 122. MacDonald PN, Sherman DR, Dowd DR, Jefcoat Jr SC, DeLisle RK 1995 The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 270:4748-4752
123. 123. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16: 200-257
124. 124. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375:377-382
125. 125. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
126. 126. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
127. 127. Tanenbaum DM, Wang Y, Williams SP, Sigler PB 1998 Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95:5998-6003
128. 128. Williams SP, Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature 393:392-396
129. 129. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H 1996 A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3:87-94
130. 130. Jin CH, Kerner SA, Hong MH, Pike JW 1996 Transcriptional activation and dimerization functions in the human vitamin D receptor. Mol Endocrinol 10:945-957
131. 131. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033
132. 132. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR 1994 The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8:159-172
133. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem 272:14592-14599
134. 134. Chen TL, Hirst MA, Cone CM, Hochberg Z, Tietze HU, Feldman D 1984 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. J Clin Endocrinol Metab 59:383-388
135. 3. Proc Natl Acad Sci USA 86:4455-4459
136. 136. Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy ML, Eisman JA 1989 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158-1161
137. 137. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888
138. 138. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G 1989 Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143-1147
139. 3. Proc Natl Acad Sci USA 87:369-373
140. 3-mediated transcriptional activation. Mol Endocrinol 5:373-385
141. 3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999
142. 3-response element in the 5′-flanking region of the rat calbindin D-9 k gene. Proc Natl Acad Sci USA 89:603-607
143. 3-and butyrate-inducible responses. Proc Natl Acad Sci USA 90: 2984-2988
144. 3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1263: 1-9
145. 145. Zierold C, Darwish HM, DeLuca HF 1995 Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 270:1675-1678
146. 146. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW 1988 Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242:1702-1705
147. 3-resistant rickets in three families. Proc Natl Acad Sci USA 86: 9783-9787
148. 3 in humans are transcriptionally inactive in vitro. J Biol Chem 264:20230-20234
149. 3 receptor regulate osteocalcin gene expression. Mol Endocrinol 3:635-644
150. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153
151. 3 receptor zinc finger region. Mol Endocrinol 5:1815-1826
152. 3-modulated heterodimer. J Biol Chem 266:23296-23305
153. 3 receptor: mechanism of dimer binding to an asymmetric repeat element. Proc Natl Acad Sci USA 90:6310-6314
154. 154. Nishikawa J, Kitaura M, Matsumoto M, Imagawa M, Nishihara T 1994 Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res 22:2902-2907
155. 3 receptor-and retinoid × receptor-mediated gene activation in vivo. Mol Cell Biol 16:1006-1016
156. 156. Whitfield GK, Hsieh JC, Nakajima S, MacDonald PN, Thompson PD, Jurutka PW, Haussler CA, Haussler MR 1995 A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol Endocrinol 9:1166-1179
157. 3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol Endocrinol 10:1617-1631
158. 158. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
159. 3. Proc Natl Acad Sci USA 87:9751-9755
160. 160. Sone T, Ozono K, Pike JW 1991 A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol Endocrinol 5:1578-1586
161. 161. MacDonald PN, Haussler CA, Terpening CM, Galligan MA, Reeder MC, Whitfield GK, Haussler MR 1991 Baculovirus-mediated expression of the human vitamin D receptor. Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor. J Biol Chem 266:18808-18813
162. 3 receptor to its response elements. Proc Natl Acad Sci USA 89:256-260
163. 163. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
164. 3 signalling. Nature 355:446-449
165. 165. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, Chambon P 1992 Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395
166. 166. Zhang XK, Haffmann B, Tran PB, Graupner G, Pfahl M 1992 Retinoid × receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446
167. 167. Perlmann T, Umesono K, Rangarajan PN, Forman BM, Evans RM 1996 Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. Mol Endocrinol 10:958-966
168. 168. Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, Silverman S, Rosenfeld MG, Glass CK 1993 Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev 7:1423-1435
169. 169. Perlmann T, Rangarajan PN, Umesono K, Evans RM 1993 Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7:1411-1422
170. 170. Forman BM, Umesono K, Chen J, Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550
171. 171. Valcarcel R, Holz H, Jimenez CG, Barettino D, Stunnenberg HG 1994 Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer. Genes Dev 8:3068-3079
172. 172. Schulman IG, Juguilon H, Evans RM 1996 Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol 16: 3807-3813
173. 173. Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H, Chambon P 1997 A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J 16:5697-5709
174. 174. Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744
175. 175. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBOJ 15:3667-3675
176. 176. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM 1997 Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580
177. 177. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404
178. 178. Yang XJ, Ogryzko W, Nishikawa J, Howard BH, Nakatani Y 1996 A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324
179. 179. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
180. 180. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
181. 181. Kurokawa R, Kalafus D, Ogliastro MH, Kioussi C, Xu L, Torchia J, Rosenfeld MG, Glass CK 1998 Differential use of CREB binding protein-coactivator complexes. Science 279:700-703
182. 182. Taunton J, Hassig CA, Schreiber SL 1996 A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408-411
183. 183. Wolffe AP 1996 Histone deacetylase: a regulator of transcription. Science 272:371-372
184. 184. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen TM, Glass CK, Rosenfeld MG 1998 Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703-707
185. 185. Zerwekh JE, Glass K, Jowsey J, Pak CY 1979 An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab 49:171-175
186. 186. Fujita T, Nomura M, Okajima S, Furuya H 1980 Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. J Clin Endocrinol Metab 50:927-931
187. 187. Tsuchiya Y, Matsuo N, Cho H, Kumagai M, Yasaka A, Suda T, Orimo H, Shiraki M 1980 An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D. J Clin Endocrinol Metab 51:685-690
188. 188. Eil C, Liberman UA, Rosen JF, Marx SJ 1981 A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N Engl J Med 304:1588-1591
189. 3. J Clin Endocrinol Metab 56:824-830
190. 3. J Clin Invest 72:1190-1199
191. 3: Association with heterogeneous defects in cultured skin fibroblasts. J Clin Invest 71:192-200
192. 192. Liberman UA, Eil C, Holst P, Rosen JF, Marx SJ 1983 Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone. J Clin Endocrinol Metab 57:958-962
193. 3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 59:556-560
194. 3 in cultured skin fibroblasts. J Clin Invest 75:954-960
195. 3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. J Clin Invest 76:2012-2015
196. 196. Castells S, Greig F, Fusi MA, Finberg L, Yasumura S, Liberman UA, Eil C, Marx SJ 1986 Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. J Clin Endocrinol Metab 63:252-256
197. 197. Liberman UA, Eil C, Marx SJ 1986 Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation. J Clin Endocrinol Metab 62:122-126
198. 198. Liberman UA, Eil C, Marx SJ 1986 Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II). Adv Exp Med Biol 196:391-406
199. 199. Sakati N, Woodhouse NJY, Niles N, Harfi H, de Grange DA, Marx S 1986 Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy. Horm Res 24:280-287
200. 200. Takeda E, Kuroda Y, Saijo T, Toshima K, Naito E, Kobashi H, Iwakuni Y, Miyao M 1986 Rapid diagnosis of vitamin D-dependent rickets type II by use of phytohemagglutinin-stimulated lymphocytes. Clin Chim Acta 155:245-250
201. 3. Br J Haematol 67:267-271
202. 3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. J Clin Invest 83:2093-2101
203. 203. Malloy PJ, Hochberg Z, Pike JW, Feldman D 1989 Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependcnt rickets, type II. J Clin Endocrinol Metab 68:263-269
204. 204. Takeda E, Yokota I, Kawakami I, Hashimoto T, Kuroda Y, Arase S 1989 Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy. Eur J Pediatr 149:54-57
205. 3 receptor. Mol Cell Endocrinol 70:1-11
206. 3 of cells from parents of patients with vitamin D-dependent rickets type II. J Clin Endocrinol Metab 70:1068-1074
207. 207. Yokota I, Takeda E, Ito M, Kobashi H, Saijo T, Kuroda Y 1991 Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II. J Inherit Metab Dis 14:231-240
208. 208. Simonin G, Chabrol B, Moulene E, Bollini G, Strouc S, Mattel JF, Giraud F 1992 Vitamin D-resistant rickets type II: apropos of 2 cases. Pediatric 47:817-820
209. 209. Lin JP, Uttley WS 1993 Intra-atrial calcium infusions, growth, and development in end organ resistance to vitamin D. Arch Dis Child 69:689-692
210. 3 in rat skin. Proc Natl Acad Sci USA 77:5822-5826
211. 3 receptors in human skin biopsies. J Clin Endocrinol Metab 51:1463-1465
212. 3 receptor. Proc Natl Acad Sci USA 79:7719-7723
213. 3. Interaction and effects of binding on receptor function. J Biol Chem 259:1167-1173
214. 3 receptors. Science 224:879-881
215. 215. Dokoh S, Haussler MR, Pike JW 1984 Development of a radioligand immunoassay for 1,25-dihydroxycholecalciferol receptors utilizing monoclonal antibody. Biochem J 221:129-136
216. 3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II. Acta Paediatr Jpn 32:39-43
217. 217. Huckaby CS, Conneely OM, Beattie WG, Dobson AD, Tsai MJ, O'Malley BW 1987 Structure of the chromosomal chicken progesterone receptor gene. Proc. Natl Acad Sci USA 84:8380-8384
218. 218. Encio IJ, Detera-Wadleigh SD 1991 The genomic structure of the human glucocorticoid receptor. J Biol Chem 266:7182-7188
219. 219. Jehan F, DeLuca HF 1997 Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci USA 94:10138-10143
220. 220. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287
221. 221. Cooper GS, Umbach DM 1996 Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11:1841-1849
222. 222. Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, Shi CY, Yu MC, Ross RK, Coetzee GA 1997 Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 6:93-98
223. 223. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Akersrtom G, Melhus H 1995 Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1:1309-1311
224. 224. Gross C, Eccleshall TR, Feldman D 1996 Vitamin D receptor gene alleles and osteoporosis. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of Bone Biology. Academic Press, San Diego, CA, pp 917-933
225. 225. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA 1996 Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 56:4108-4110
226. 226. Feldman D 1997 Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk. J Natl Cancer Inst 89:109-111
227. 227. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera C, Haile RW, Coetzee GA 1997 Association of prostate cancer with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89:166-170
228. 228. Keen RW, Hart DJ, Lanchbury JS, Spector TD 1997 Association of early osteoarthritis of the knee with a TaqI polymorphism of the vitamin D receptor gene. Arthritis Rheum 40:1444-1449
229. 229. Uitterlinden AG, Burger H, Huang Q, Odding E, van Duijn CM, Hofman A, Birkenhager JC, van Leeuwen JPTM, Pols HAP 1997 Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee. J Clin Invest 100:259-263
230. 230. Mocharla H, Butch AW, Pappas AA, Flick JT, Weinstein RS, De Tongi P, Jilka RL, Roberson PK, Parfitt AM, Manolagas SC 1997 Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res 12:726-733
231. 231. Verbeek W, Gombart AF, Shiohara M, Campbell M, Koeffler HP 1997 Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the TaqI restriction enzyme polymorphism. Biochem Biophys Res Commun 238:77-80
232. 232. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao X-Y, Feldman D 1998 The vitamin D receptor gene start codon polymorphism: a functional analysis of Fok I variants. J Bone Miner Res 13:1691-1699
233. 233. Saijo T, Ito M, Takeda E, Huq AH, Naito E, Yokota I, Sone T, Pike JW, Kuroda Y 1991 A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet 49:668-673
234. 234. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D 1996 The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11:1850-1855
235. 235. Arai H, Miyamoto K-I, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E 1997 A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12:915-921
236. 236. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D 1997 The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12:1043-1048
237. 237. Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D 1998 Lack of correlation between the start codon polymorphism of the vitamin D receptor and bone mineral density in premenopausal French women. J Bone Miner Res 13:31-35
238. 238. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA 1988 Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491
239. 239. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
240. 240. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
241. 241. Werner S, Bronnegard M 1996 Molecular basis of glucocorticoid-resistant syndromes. Steroids 61:216-221
242. 242. Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP 1998 Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 19:279-281
243. 3. Mol Endocrinol 4:623-631
244. 244. Rut AR, Hewison M, Kristjansson K, Luisi B, Hughes MR, O'Riordan JL 1994 Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures. Clin Endocrinol (Oxf) 41:581-590
245. 245. Wiese RJ, Goto H, Prahl JM, Marx SJ, Thomas M, al-Aqeel A, DeLuca HF 1993 Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds. Mol Cell Endocrinol 90:197-201
246. 246. Cockerill FJ, Hawa NS, Yousaf N, Hewison M, O'Riordan JL, Farrow SM 1997 Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. J Clin Endocrinol Metab 82:3156-3160
247. 247. Lin NU-T, Malloy PJ, Sakati N, Al-Ashwal A, Feldman D 1996 A novel mutation in the deoxyribnucleic acid-binding domain of the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D resistant rickets. J Clin Endocrinol Metab 81:2564-2569
248. 248. Zhu WJ, Malloy PJ, Delvin E, Chabot G, Feldman D 1998 Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor. J Bone Miner Res 13:259-264
249. 3-resistant rickets. J Clin Endocrinol Metab 82:3892-3894
250. 250. Freedman LP, Luisi BF 1993 On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective. J Cell Biochem 51:140-150
251. 251. Luisi BF, Schwabe JW, Freedman LP 1994 The steroid/nuclear receptors: from three-dimensional structure to complex function. Vitam Horm 49:1-47
252. 252. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M 1994 Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367:476-480
253. 3-induced gene transcription. J Bone Miner Res 9:S145 (Abstract 97)
254. 254. Dedhar S, Rennie PS, Shago M, Leung Hagesteijn C-Y, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ, Giguere V 1994 Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483
255. 255. Orkin SH 1984 The mutation and polymorphism of the human §-globin gene and its surrounding DNA. Annu Rev Genet 18:131-171
256. 256. Neufeld EF 1989 Natural history and inherited disorders of a lysosomal enzyme, β-hexosaminidase. J Biol Chem 264:10927-10930
257. 257. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ 1989 The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578-1580
258. 258. Malloy PJ, Hughes MR, Pike JW, Feldman D 1991 Vitamin D receptor mutations and hereditary 1,25-dihydroxyvitamin D resistant rickets. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D. Walter de Gruyter, New York, pp 116-124
259. 259. Rut AR, Hewison M, Rowe P, Hughes M, Grant D, O'Riordan JLH 1991 A novel mutation in the steroid binding region of the vitamin D receptor (VDR) gene in hereditary vitamin D resistant rickets (HVDRR). In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D. Walter de Gruyter, New York, pp 94-95
260. 3. J Clin Invest 92:12-16
261. 261. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D 1997 Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest 99:297-304
262. 262. Van Maldergem L, Bachy A, Feldman D, Bouillon R, Maassen J, Dreyer M, Rey R, Holm C, Gillerot Y 1996 Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent mullerian ducts in a Turkish boy born to consanguineous parents. Am J Med Genet 64:506-513
263. 263. Thompson E, Kristjansson K, Hughes M 1991 Molecular scanning methods for mutation detection: application to the 1,25-dihydroxyvitamin D receptor. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D. Walter de Gruyter, New York, (Abstract), p 6
264. 264. Hawa NS, Cockerill FJ, Vadher S, Hewison M, Rut AR, Pike JW, O'Riordan JL, Farrow SM 1996 Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping. Clin Endocrinol (Oxf) 45:85-92
265. 265. Hewison M, Rut AR, Kristjansson K, Walker RE, Dillon MJ, Hughes MR, O'Riordan JL 1993 Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin Endocrinol (Oxf) 39:663-670
266. 266. Giraldo A, Pino W, Garcia-Ramirez LF, Pineda M, Iglesias A 1995 Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children. Clin Genet 48:57-65
267. 267. Kruse K, Feldmann E 1995 Healing of rickets during vitamin D therapy despite defective vitamin D receptors in two siblings with vitamin D-dependent rickets type II. J Pediatr 126:145-148
268. 268. Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C 1986 Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 77:1661-1667
269. 269. Weisman Y, Bab I, Gazit D, Spirer Z, Jaffe M, Hochberg Z 1987 Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am J Med 83:984-990
270. 270. Hochberg Z, Tiosano D, Even L 1992 Calcium therapy for calcitriol-resistant rickets. J Pediatr 121:803-808
271. 271. Weisman Y, Jaccard N, Legum C, Spirer Z, Yedwab G, Even L, Edelstein S, Kaye AM, Hochberg Z 1990 Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues. J Clin Endocrinol Metab 71:937-943
272. 3 binding, 24-hydroxylase induction and RFLP analysis. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: A Pluripotent Steroid Hormone. Structural Studies, Molecular Endocrinology and Clinical Applications. Ninth Workshop on Vitamin D (Abstract), p 106
273. 273. Underwood JL, DeLuca HF 1984 Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol 246:E493-E-498